Boston Scientific Closes Acquisition of Neovasc Advanced Biological Tissue Capabilities, Acquires 15% Stake
With the completion of the acquisition, Boston Scientific will integrate certain manufacturing assets and biologic tissue capabilities into its structural heart business for use in the manufacturing of the Lotus™ Valve System* and future heart valve technologies. The two organizations announced a definitive agreement for Boston Scientific to acquire the advanced biologic tissue capabilities and[…]